OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
7
Results
Show all
Save search
Copy query
Show results for
Unknown
(6)
Proteomics
(1)
Organisms
Homo sapiens
(1)
Repository
pride
(1)
Tissue
Breast
(1)
Disease
Breast cancer
(1)
Technology Type
Bottom-up proteomics
(1)
Mass Spectrometry
(1)
Publication Date
2025
(1)
Release Date
2021
(3)
2024
(1)
2022
(1)
2016
(1)
Lab affiliation
Mass Spectrometry Facility Barts Cancer Institute, Queen Mary,University of LondonRoom 1.02-1.03, 1st Floor, John Vane Science Centre Charterhouse Square London EC1M 6BQ
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Integrative proteo-genomic profiling uncovers key biomarkers of lapatinib resistance in HER2-positive breast cancer
To understand the transcriptomic, genomic and proteomics changes between HER2 overexpressingcells and those that have become resistant to lapatinib
ORGANISM(S):
Homo sapiens (Human)
2025-11-17
|
PXD056848
|
Pride
3d
Chromatin
Proteomics
Epigenetics
Resistance
Her2
Lc-ms/ms
Cite
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Not available
S-EPMC4985288
|
biostudies-literature
Cite
Protecting stable biological nomenclatural systems enables universal communication: A collective international appeal.
Not available
S-EPMC11328142
|
biostudies-literature
Cite
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study.
Not available
S-EPMC7995808
|
biostudies-literature
Cite
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study.
Not available
S-EPMC8206995
|
biostudies-literature
Cite
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
Not available
S-EPMC8652887
|
biostudies-literature
Cite
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study.
Not available
S-EPMC7906623
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets